EC Gynaecology

Objectives: P-PROM is associated with 30 - 40% of preterm deliveries and is the leading identifiable cause of preterm delivery. The objective of our study is to evaluate incidence and management of P-PROM.

Materials and Methods: During the study period, from 2019 to 2023 in University Hospital Maternity “Queen Geraldine” preterm births data were statistically analyzed. All data analyses were performed using Microsoft Excel and WINPEPI version 11.65. The p-value was considered significant at < 0.05.

Results: The percentage of premature births varied, with the highest rate of 8.4% in 2022 and the lowest rate of 6.14% in 2020. P-PROM (Total) cases showed a peak of 3.27% in 2022 and a low of 2.19% in 2023. Within the P-PROM categories, P-PROM (24-29w6d) ranged from 0.13% to 0.38%, P-PROM (30-33w6d) ranged from 0.21% to 0.52%, and P-PROM (34-36w6d) ranged from 1.73% to 2.36%.

Conclusion: Globally, the magnitude of P-PROM slightly varies and it complicates approximately 1 - 4% of all pregnancies. Premature births with a gestational age of 34 - 37 weeks constitute the largest number of premature births with ruptured membranes. In cases of early PPROM, a waiting attitude is preferred. If mother and fetus are clinically stable, without any sign of infection, gestational age is the main factor determining management.

 Keyword: Preterm Premature Rupture of Membranes (P-PROM)

1. Tsakiridis I., et al. “Preterm premature rupture of membranes: a review of 3 national guidelines”. Obstetrical and Gynecological Survey 6 (2018): 368-375.
2. Liu L., et al. “Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals”. Lancet10063 (2016): 3027-3035.
3. Savitz DA and Murnane P. “Behavioral influences on preterm birth: A review”. Epidemiology3 (2010): 291-299.
4. Alexander JM., et al. “The impact of digital cervical examination on expectantly managed preterm rupture of membranes”. American Journal of Obstetrics and Gynecology 4 (2000): 1003-1007.
5. “Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217”. Obstetrics and Gynecology 3 (2020): e80-e97.
6. Seelbach-Goebel B. “Antibiotic therapy for premature rupture of membranes and preterm labor and effect on fetal outcome”. Geburtshilfe und Frauenheilkunde 12 (2013): 1218-1227.
7. Mercer BM. “Is there a role for tocolytic therapy during conservative management of preterm premature rupture of the membranes?” Clinical Obstetrics and Gynecology 2 (2007): 487-496.
8. Pasquier JC., et al. “Intentional early delivery versus expectant management for preterm premature rupture of membranes at 28-32 weeks’ gestation: A multicentre randomized controlled trial (MICADO STUDY)”. European Journal of Obstetrics and Gynecology and Reproductive Biology 233 (2019): 30-37.
9. Schmitz T., et al. “Preterm premature rupture of the membranes: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF)”. European Journal of Obstetrics and Gynecology and Reproductive Biology 236 (2019): 1-6.
10. Bond DM., et al. “Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome”. Cochrane Database of Systematic Reviews 3 (2017): CD004735.